A generalized drift-diffusion model for rectifying Schottky contact simulation

We present a discussion on the modeling of Schottky barrier rectifying contacts (diodes) within the framework of partial-differential-equation-based physical simulations. We propose a physically consistent generalization of the drift-diffusion model to describe the boundary layer close to the Schottky barrier where thermionic emission leads to a non-Maxwellian carrier distribution, including a novel boundary condition at the contact. The modified drift-diffusion model is validated against Monte Carlo simulations of a GaAs device. The proposed model is in agreement with the Monte Carlo simulations not only in the current value but also in the spatial distributions of microscopic quantities like the electron velocity and concentratio

Evaluating the Impedance Field through several transport models: a comparison

J. APPL. PHYS

Assessment of pesticide environmental risks in annual crops in center of Santa Fe

Los plaguicidas permiten alcanzar la productividad y la sustentabilidad si se manejan adecuadamente. La elaboración de indicadores permite cuantificar el impacto ambiental de un fitosanitario. El objetivo de este trabajo fue determinar el impacto ambiental de plaguicidas sobre el suelo y el agua en lotes de agricultura del centro de Santa Fe con tres indicadores: GUS, Ipest e Índice relativo de Plaguicidas. El trabajo se realizó en 25 establecimientos cuyos registros de aplicaciones en cultivos de soja, maíz y trigo se relevaron entre 2007 y 2011. Se calcularon los tres indicadores y se compararon los resultados obtenidos. El maíz fue el cultivo con mayor riesgo de impacto ambiental por el uso intensivo de atrazina. En trigo y soja, los ingredientes activos empleados tuvieron bajo impacto ambiental. El empleo de indicadores contribuye a seleccionar plaguicidas con mejor comportamiento ambiental y realizar una planificación más sustentable de los cultivos.Pesticides are essential tools to achieve productivity and sustainability in agricultural crops when they are applied minimizing undesirable effects. Pesticide environmental impact is related to toxicity and time of exposure. Several indicators allow the calculation of this impact: GUS, IPEST and Relative Pesticide Index. Our aim was the evaluation of pesticide environmental impact on soil and water in agricultural fields of Central Santa Fe with those three indicators. All pesticide treatments applied in soybean, wheat and corn in 25 farms were recorded from 2007 and 2011, also with soil properties and pesticide characteristics. Indicators were calculated and the results were compared. Corn has the highest risk of pesticide contamination in soil and water, related to the frequent use of atrazine. Wheat and soybean had less environmental impact. The application of indicators may be helpful for considering the use of new active ingredients and their relationship with sustainable systems.Fil: Arregui, Maria Cristina. Universidad Nacional del Litoral. Facultad de Ciencias Agrarias; ArgentinaFil: Grenon, Daniel Arnaldo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ciencias Agrarias; ArgentinaFil: Sánchez, D.. Universidad Nacional del Litoral. Facultad de Ciencias Agrarias; ArgentinaFil: Ghione, J.. Universidad Nacional del Litoral. Facultad de Ciencias Agrarias; Argentin

Influencia del procesamiento del fruto de membrillo (Cydonia Oblonga Miller) en el contenido de polifenoles y actividad antioxidante del mismo.

Los polifenoles son metabolitos secundarios presentes en gran proporción en las frutas, en su mayoría representados por los flavonoides y ácidos fenólicos. El creciente interés por estas sustancias es principalmente debido a su capacidad antioxidante y la asociación entre su consumo y la prevención de algunas enfermedades. Entre las frutas, el membrillo es una importante fuente de componentes que promueven la salud, tales como compuestos fenólicos. Si bien el membrillo no se consume fresco debido a su dureza, amargor y astringencia, es muy apreciado como materia prima para la producción de dulces y jaleas. El objetivo de este trabajo fue evaluar la propiedad antioxidante del fruto de membrillo, su dulce y los productos intermediarios de su elaboración, con el fin de estudiar el efecto del procesado térmico en las características nutricionales del mismo. Se analizaron el fruto (pulpa+piel), la mezcla cruda (pulpa+piel+azúcar) y el dulce regular y el reducido en carbohidratos. Se midió el contenido de polifenoles totales (PT), perfil de polifenoles por HPLC-DAD-MSMS y la actividad antioxidante in vitro por las técnicas DPPH (capacidad de atrapamiento de radicales libres) y FRAP (poder reductor). Todas las muestras analizadas presentaron un alto contenido de polifenoles en un rango de 200-500 mg ac. gálico/100g muestra (futo, mezcla cruda, dulce). Se demostró la actividad antioxidante in vitro por ambos métodos en todas las muestras. Los valores obtenidos variaron entre 400 y 1500 μmol TROLOX/100g muestra (futo, mezcla cruda, dulce). Tanto para la línea regular como la reducido en carbohidratos se mantuvo el contenido de polifenoles desde el fruto al dulce, conteniendo el regular 370 mg de ác. gálico/100 g de dulce y el light 184 mg ác. gálico/100g de dulce. Por otro lado se lograron identificar 16 compuestos polifenólicos, siendo los mayoritarios los ácidos cafeoil-quínicos, seguidos por los derivados del ácido cumárico, catequina y quercetina. La proporción de los distintos compuestos también se mantuvo desde el fruto al dulce, lo que significa que el procesado térmico no afecta cuantitativamente ni cualitativamente el contenido de polifenoles. Con respecto a la capacidad antioxidante determinada por DPPH y FRAP, como era de esperarse al mantenerse el contenido de polifenoles, no hubo tampoco pérdida de la actividad debido al procesamiento del membrillo. Los resultados obtenidos demuestran que el dulce de membrillo realiza un aporte importante de antioxidantes en la dieta, y además que no existe perdida en la calidad nutricional debido al procesado térmico.publishedVersio

Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial

Background: Few data are available on long-term follow-up of drug-eluting stents in the treatment of chronic total occlusion (CTO). The LEADERS CTO sub-study compared the long-term results in CTO and non-CTO lesions of a Biolimus A9™-eluting stent (BES) with a sirolimus-eluting stent (SES).Methods: Among 1,707 patients enrolled in the prospective, multi-center, all-comers LEADERS trial, 81 with CTOs were treated with either a BES (n = 45) or a SES (n = 36). The primary endpoint was the occurrence of major adverse cardiac events (MACE): cardiac death, myocardial infarction (MI) and clinically-indicated target vessel revascularization (TVR).Results: At 5 years, the rate of MACE was numerically higher in the CTO group than in the non-CTO group (29.6% vs. 23.3%; p = 0.173), with a significant increase in the incidence of target lesion revascularization (TLR) (21.0 vs. 12.6; p = 0.033), but no difference in stent thrombosis (ST). Patients with CTO receiving a BES demonstrated a lower incidence of MACE (22.2% vs. 38.9%; p = 0.147) with a significant reduction in TLR compared to patients receiving a SES (11.1% vs. 33.3%, p = 0.0214) with an incidence similar to that observed in the non-CTO group treated with BES (11.6%). Definite ST at 5 years nearly halved in the BES group (4.4% vs. 8.3%, p = 0.478) with no ST in the BES group after the first year (0% vs. 8.3%, p for interaction = 0.009).Conclusions: The use of a BES showed a reduction in MACE, TVR, TLR, and ST over time in the CTO subset with similar outcome as for non-CTO lesions

Cardiovascular mortality and exposure to extremely low frequency magnetic fields: a cohort study of Swiss railway workers

<p>Abstract</p> <p>Background</p> <p>Exposure to intermittent magnetic fields of 16 Hz has been shown to reduce heart rate variability, and decreased heart rate variability predicts cardiovascular mortality. We examined mortality from cardiovascular causes in railway workers exposed to varying degrees to intermittent 16.7 Hz magnetic fields.</p> <p>Methods</p> <p>We studied a cohort of 20,141 Swiss railway employees between 1972 and 2002, including highly exposed train drivers (median lifetime exposure 120.5 μT-years), and less or little exposed shunting yard engineers (42.1 μT-years), train attendants (13.3 μT-years) and station masters (5.7 μT-years). During 464,129 person-years of follow up, 5,413 deaths were recorded and 3,594 deaths were attributed to cardio-vascular diseases. We analyzed data using Cox proportional hazards models.</p> <p>Results</p> <p>For all cardiovascular mortality the hazard ratio compared to station masters was 0.99 (95%CI: 0.91, 1.08) in train drivers, 1.13 (95%CI: 0.98, 1.30) in shunting yard engineers, and 1.09 (95%CI: 1.00, 1.19) in train attendants.Corresponding hazard ratios for arrhythmia related deaths were 1.04 (95%CI: 0.68, 1.59), 0.58 (95%CI: 0.24, 1.37) and 1.30 (95%CI: 0.87, 1.93) and for acute myocardial infarction 1.00 (95%CI: 0.73, 1.36), 1.56 (95%CI: 1.04, 2.32), and 1.14 (95%CI: 0.85, 1.53). The hazard ratio for arrhythmia related deaths per 100 μT-years of cumulative exposure was 0.94 (95%CI: 0.71, 1.24) and 0.91 (95%CI: 0.75, 1.11) for acute myocardial infarction.</p> <p>Conclusion</p> <p>This study provides evidence against an association between long-term occupational exposure to intermittent 16.7 Hz magnetic fields and cardiovascular mortality.</p

A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi

Abstract Background Carmustine (BCNU)-Etoposide-Citarabine-Melphalan (BEAM) chemotherapy is the standard conditioning regimen for autologous stem cell transplantation (ASCT) in lymphomas. Owing to BCNU shortages, many centers switched to Fotemustine-substituted BEAM (FEAM), lacking proof of equivalence. Methods We conducted a retrospective cohort study in 18 Italian centers to compare safety and efficacy of BEAM and FEAM regimens for ASCT in lymphomas performed from 2008 to 2015. Results We enrolled 1038 patients (BEAM n=607, FEAM n=431), of which 27% had Hodgkin's lymphoma (HL), 14% indolent Non-Hodgkin's lymphoma (iNHL) and 59% aggressive NHL (aNHL). Baseline characteristics including age, sex, stage, B-symptoms, extranodal involvement, previous treatments, response before ASCT, overall conditioning intensity, were well balanced between BEAM and FEAM; notable exceptions were: ASCT year (median: BEAM=2011 vs FEAM=2013, p Conclusions BEAM and FEAM do not appear different in terms of survival and disease control. However, due to concerns of higher toxicity, Fotemustine substitution in BEAM does not seem justified, if not for easier supply

Mating plugs in polyandrous giants: Which sex produces them, when, how and why?

10.1371/journal.pone.0040939PLoS ONE77

Pasquale del Pezzo, Duke of Caianello, Neapolitan mathematician

This article is dedicated to a reconstruction of some events and achievements, both personal and scientific, in the life of the Neapolitan mathematician Pasquale del Pezzo, Duke of Caianello

Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial.

BACKGROUND Few data are available on long-term follow-up of DES in the treatment of chronic total occlusion (CTO). The LEADERS CTO sub-study compared the long-term results in CTO and non-CTO lesions of a Biolimus A9™-eluting stent (BES) with a sirolimus-eluting stent (SES). METHODS Among 1,707 patients enrolled in the prospective, multi-center, all-comers LEADERS trial, 81 with CTOs were treated with either a BES (n = 45) or a SES (n = 36). The primary endpoint was the occurrence of major adverse cardiac events (MACE): cardiac death, myocardial infarction (MI) and clinically-indicated target vessel revascularization (TVR). RESULTS At 5 years, the rate of MACE was numerically higher in the CTO group than in the non-CTO group (29.6% vs. 23.3%; p = 0.173), with a significant increase in the incidence of target lesion revascularization (TLR) (21.0 vs. 12.6; p = 0.033), but no difference in stent thrombosis (ST). Patients with CTO receiving a BES demonstrated a lower incidence of MACE (22.2% vs. 38.9%; p = 0.147) with a significant reduction in TLR compared to patients receiving a SES (11.1% vs. 33.3%, p = 0.0214) with an incidence similar to that observed in the non-CTO group treated with BES (11.6%). Definite ST at 5 years nearly halved in the BES group (4.4% vs. 8.3%, p = 0.478) with no ST in the BES group after the first year (0% vs. 8.3%, p for interaction = 0.009). CONCLUSIONS The use of a BES showed a reduction in MACE, TVR, TLR, and ST over time in the CTO subset with similar outcome as for non-CTO lesions